Clinical Trials Directory

Trials / Completed

CompletedNCT02730585

Diagnostic Performance of C Reactive Protein and Delta CRP in Acute Appendicitis

Evaluation of the Performance of C-reactive Protein (CRP) Concentrations Variation (Delta CRP) in the Diagnosis of Acute Appendicitis in the ER

Status
Completed
Phase
Study type
Observational
Enrollment
500 (actual)
Sponsor
University of Monastir · Academic / Other
Sex
All
Age
10 Years
Healthy volunteers
Not accepted

Summary

The diagnosis of acute appendicitis is difficult and despite important advances in medical sciences, detailed patient questioning and precise medical examination are the main keystones of the diagnosis of acute appendicitis and up to now, results still unsatisfactory.

Detailed description

Acute appendicitis is the most common surgical emergency and the most common source of community-acquired intra-abdominal infections. The lack of accuracy in the diagnosis of acute appendicitis yields often to two types of outcomes: a delay in diagnosis leads to perforation and peritonitis in up to 15% of the cases and unnecessary appendectomy is associated with post-operative complications such as wound infection and adhesions. CRP is an acute phase protein that is often used by many surgeons as a diagnostic marker of acute appendicitis. During the evaluation of patients with possible appendicitis in the emergency department (ED), repeated physical examination of the abdomen may provide further information about the decision making. However, the role of repeated laboratory examinations is not proven. The purpose of this study was to investigate whether repeated serum CRP measures could be useful to predict acute appendicitis, after 3 hours of observation, in comparison with the histopathological findings.

Conditions

Interventions

TypeNameDescription
BIOLOGICALC-reactive protein measurementAll patients included in this study underwent a blood sample analysis for C-reactive protein concentrations at admission and 3 hours later.

Timeline

Start date
2010-01-01
Primary completion
2013-12-01
Completion
2013-12-01
First posted
2016-04-06
Last updated
2016-09-01

Locations

1 site across 1 country: Tunisia

Source: ClinicalTrials.gov record NCT02730585. Inclusion in this directory is not an endorsement.